MTOR Human shRNA Plasmid Kit (Locus ID 2475)
CAT#: TG320364
MTOR - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (2)
MTOR mouse monoclonal antibody, clone OTI3E5 (formerly 3E5)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | MTOR Human shRNA Plasmid Kit (Locus ID 2475) |
Locus ID | 2475 |
UniProt ID | P42345 |
Synonyms | FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | MTOR - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 2475). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_004958, NM_004958.1, NM_004958.2, NM_004958.3, BC117166 |
Summary | The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This kinase is a component of two distinct complexes, mTORC1, which controls protein synthesis, cell growth and proliferation, and mTORC2, which is a regulator of the actin cytoskeleton, and promotes cell survival and cell cycle progression. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. Inhibitors of mTOR are used in organ transplants as immunosuppressants, and are being evaluated for their therapeutic potential in SARS-CoV-2 infections. Mutations in this gene are associated with Smith-Kingsmore syndrome and somatic focal cortical dysplasia type II. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Aug 2020] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Inactivation of the mTORC1-Eukaryotic Translation Initiation Factor 4E Pathway Alters Stress Granule Formation
,Marie-Josée Fournier, Laetitia Coudert, Samia Mellaoui, Pauline Adjibade, Cristina Gareau, Marie-France Côté, Nahum Sonenberg, René C. Gaudreault, and Rachid Mazroui,
Mol. Cell. Biol., Jun 2013; 33: 2285 - 2301.
,PubMed ID 23547259
[mTOR]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...